Navigation Links
Behavioral Health Group (BHG) Outpatient Opioid Treatment Centers Offer New Medication Option for Patients
Date:5/8/2013

DALLAS, May 8, 2013 /PRNewswire/ --  Michael Cannizzaro , Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced that BHG treatment centers are now offering both Buprenorphine and Methadone in their medication-assisted treatment programs.

Mr. Cannizzaro said, "BHG's outpatient opioid addiction treatment centers address each patient's physical opioid addiction with either Methadone or Buprenorphine medications in combination with counseling and skill development.  This expanded service offering demonstrates our commitment to helping each individual patient achieve his/her best functional level in the community."

Kelly Clark , MD, BHG Chief Medical Officer, commented, "Since most patients will be clinically appropriate for either Buprenorphine or Methadone medication, the choice of which medication each patient will try will usually be decided by the patient in consultation with his/her physician.  Most patients will do well on either medication, while a few will only do well on one or the other.  This additional medication option offers a choice for patients, especially those with medical conditions."

BHG's mission is to achieve positive patient outcomes by using medication-assisted treatment at the lowest possible medication dosage combined with behavioral therapy to control medical and behavioral signs of opioid addiction within an outpatient setting. 

About Behavioral Health Group

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services.  BHG utilizes pharmacotherapy (maintenance and detoxification) as well as counseling to treat both the bio-chemical and psychosocial aspects of addiction.  In doing so, BHG offers patients their best opportunity for a successful recovery.  With 29 outpatient treatment centers across the Midwest/South/Southeast, BHG provides a critical service to thousands of individuals and their communities across the country.  BHG treatment centers are accredited by The Joint Commission.

For more information, phone 214-365-6187, email inquiries@bhgrecovery.com or visit www.bhgrecovery.com.

 


'/>"/>
SOURCE Behavioral Health Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DocuTrac, Inc. Provides Cloud Hosted Solution for Behavioral Health Providers
2. Millennium HealthCare Signs Exclusive Distribution Agreement with Heart Smart Inc.
3. Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
4. Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference
5. Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
6. Cynosure to Present at UBS Global Healthcare Conference
7. Actavis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
8. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
9. BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
10. Cantel Medical To Present At The Bank Of America Merrill Lynch Health Care Conference
11. Smart Water Leadership Summit Focused On Waterborne Disease Prevention in Healthcare Facilities To Be Held In Chicago June 6 & 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to ... Surgery Devices Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume ... - Canaloplasty Micro Catheters and Glaucoma Drainage Devices. ... data for each of these market segements, and global ...
(Date:12/5/2016)... -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ), the ... and manufacturing data that support SB-525, its gene therapy program ... of the American Society of Hematology (ASH) being held in ... 2016. "We have developed an improved gene therapy ... highly competitive, and we remain on track to file an ...
(Date:12/5/2016)... Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., a ... data from two Phase I trials evaluating its ... 58th annual meeting of the American Society of ... . The two datasets show encouraging efficacy ... leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell NHL), ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... 2016 , ... "FCPX Overlay Glare is a tool that utilizes light found ... or complicated compositing," said Christina Austin - CEO of Pixel Film Studios. , ... lights that simulates the look of a glare. Just drag and drop to ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... been featured in SuperbCrew magazine, a leading online tech news platform connecting technology ... now featured on SuperbCrew.com, explores the state of enterprise mobility security today, and ...
(Date:12/5/2016)... ... , ... “Epilepsy Awareness,” which can be found at the ... about epilepsy, bearing down on the social stigma and lack of public education ... within their lifetime. With such a large percentage of people affected, it’s critically ...
(Date:12/5/2016)... ... December 05, 2016 , ... Eating disorders are equal ... Castlewood Treatment Centers has always been to promote the power of recovery, and ... possible. In that spirit, Castlewood has announced two new hires, both Outreach Directors ...
(Date:12/5/2016)... Shrewsbury, PA (PRWEB) , ... December 05, 2016 , ... ... of necessity for the betterment of both the smaller rider and the horse. Smaller ... performance. The Saddle Sidekick is designed to fit over a properly fitted western saddle ...
Breaking Medicine News(10 mins):